Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.
Chase has the proven ability to rapidly translate advances in the basic neurosciences into safer and more effective approaches to the treatment of neurologic and psychiatric disease.The company pipeline now holds several promising drugs in mid-stage development. One compound i...
Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.
Chase has the proven ability to rapidly translate advances in the basic neurosciences into safer and more effective approaches to the treatment of neurologic and psychiatric disease.The company pipeline now holds several promising drugs in mid-stage development. One compound is currently in Phase 2 trials for major depressive disorder. Another is about to enter Phase 2 studies to evaluate both palliative and neuroprotective benefit in patients with Parkinson’s disease.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.